International Journal of Head and Neck Surgery

Register      Login

VOLUME 9 , ISSUE 4 ( October-December, 2018 ) > List of Articles

CASE REPORT

Onchocerciasis in the Orbital Region: An Unexpected Guest From Tropics

Nagaraj T Mayappa, Madhu R Jeyasekar

Keywords : India, Onchocerca volvulus, Orbit, River blindness

Citation Information : Mayappa NT, Jeyasekar MR. Onchocerciasis in the Orbital Region: An Unexpected Guest From Tropics. Int J Head Neck Surg 2018; 9 (4):137-139.

DOI: 10.5005/jp-journals-10001-1376

License: CC BY-NC 4.0

Published Online: 01-11-2019

Copyright Statement:  Copyright © 2018; The Author(s).


Abstract

Background: Onchocerciasis is the world's second commonest infectious cause of blindness. It is transmitted by the bite of the Simulium blackfly, which transmits the infective-stage larva into the human skin and mainly affects the people in the rural areas of Sub-Saharan Africa, Yemen, and those living in parts of Central and South Africa. The first case of ocular onchocerciasis in India was a woman from rural Assam, northeastern India reported in 2011. Here we report a rare case of onchocerciasis—a patient from a non-endemic region of Bengaluru, India, showing a swelling in the orbital region. Case description: A 55-year-old women was presented to our outpatient department with the complaints of a swelling below the left eyebrow since 2 months and drooping of the left upper eyelid since 1 month. The patient underwent excision of the swelling after CT and FNAC of the swelling. The worm in the wall of the excised cyst was identified as Onchocerca volvulus, on the basis of morphological features observed in histopathology. The patient was treated with a single oral dose of Ivermectin (150 μg/kg), and on follow-up at 4 months, she has not shown any recurrence of symptoms or fresh complaints. Conclusion: Onchocerciasis, though rare, can be a differential diagnosis of a subcutaneous swelling in the body. Clinical significance: Knowledge and awareness regarding the presence of this filarial worm in India is required, as it is rare and reporting of further cases needs to be done.


HTML PDF Share
  1. Bradley JE, Whitworth J, et al. Onchocerciasis. Cox F, Wakelin D, et al. Topley & Wilson's microbiology and microbial infection. London: Arnold Hodder; 2005. pp. 781–801.
  2. Basanez MG, Pion SD, et al. River blindness, a success story under threat? PLoS Medicine 2006;3:e371. DOI: 10.1371/journal.pmed.0030371.
  3. Centers for Disease Control and Prevention (CDC). Progress toward elimination of onchocerciasis in the Americas-1993–2012. Morb Mortal Wkly Rep 2013;62(20):405–408.
  4. Bradley JE, Nirmalan N, et al. River blindness: a role for parasite retinoid binding proteins in the generation of pathology? Trends Parasitol 2001;17(10):471–475. DOI: 10.1016/S1471-4922(01)02036-0.
  5. Barua P, Sharma A, et al. A rare case of ocular onchocerciasis in india. Southeast Asian J Trop Med Public Health November 2011;42(6): 1359–1364.
  6. Richards FO, Boatin B, et al. Control of onchocerciasis today: status and challenges. Trends Parasitol 2001;17(12):558–563. DOI: 10.1016/S1471-4922(01)02112-2.
  7. Diawara L, Traoré MO, et al. Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal. PLoS Negl Trop Dis 2009;3(7):e497.
  8. Eberhard ML, Sims AC, et al. Ocular zoonotic onchocerca infection in a resident of oregon. Am J Trop Med Hyg 2012;87(6):1073–1075. DOI: 10.4269/ajtmh.2012.12-0469.
  9. Rossi K. FDA Approves Moxidectin for Onchocerciasis. Available from: http://www.raredr.com/news/fda-approves-moxidectin-onchocerciasis. [Accessed 3rd December 2018].
  10. Centers for Disease Control and Prevention (CDC), DPDx-Laboratory Identification of Parasites of Public Health Concern-Onchocerciasis. Available from: https://www.cdc.gov/dpdx/onchocerciasis/index.html. [Accessed 25th December 2018].
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.